Generally, primary BAs are synthesized by the rate-limiting enzyme cholesterol 7α-hydroxylase 16 (CYP7A1) and then conjugated with amino acids in the liver. 19 Most conjugated BAs released into the 17 intestine are reabsorbed from the distal ileum and transported into the portal vein for circulation back 18 to the liver, a process known as enterohepatic circulation. 19 A small amount of BAs escaping enteric 19 absorption is ultimately excreted in the stool daily, and they can be replenished by hepatic de novo 20 synthesis. 20 The rate of hepatic BA synthesis is reversibly controlled by Farnesoid X receptor (FXR)-21 mediated feedback mechanisms in the liver and ileum. 21 Moreover, gut microbiota, as an indispensable 22 participant in BA metabolism, is responsible for conversion of primary BAs into secondary BAs in the 23 GI tract. 20 And they also control host BA synthesis by affecting intestinal FXR-mediated feedback 24 signaling. 
MATERIALS AND METHODS

17
Subject recruitment and sample collection 18 A total of 345 IBS-D adults meeting Rome IV criteria were prospectively recruited at two Chinese 
RESULTS
14
Higher levels of BA synthesis in the subgroup of IBS-D patients with excessive BA excretion
15
A total of 345 IBS-D adults meeting ROME IV criteria were recruited, of which 290 patients completed 16 all biochemical tests and consented to voluntarily provide biospecimens for the current study.
17
Meanwhile, 91 age-and gender-matched HC subjects were recruited, of whom 89 provided 18 biospecimens. As shown in conjugated BAs and free primary BAs largely dominated the total serum BA pool in this cohort. (Figure S4D-E) . Given the inhibitory impact of natural BA products on FXR activation, 42 24 we supposed that the excess of BAs (TβMCA, TCA and TCDCA and TUDCA), consistently detected physiological and pathophysiological conditions. The fact that BA metabolites are natural ligands for 10 FXR argues strongly for the conclusion that the effect of Clostridia-rich microbiota on intestinal 11 FXR/FGF19 signaling is mediated by BA products derived from specific microbial biotransformation.
12
BA biotransformation of IBS gut microbiota has been put less attention, with only one study 13 showing a lower deconjugating activity of fecal bacteria isolated from IBS patients relative to 14 controls. 13 Consistently, we found that the Clostridia-rich microbiota in human and mice showed a Moreover, the FXR/SHP signaling in liver, known to negatively regulate gene transcription of 12 hepatic BA synthetase, 56 was also attenuated in mice colonized with Clostridia-rich microbiota and C. propose that the Clostridia-rich microbiota result in a specific composition of BAs that attenuate 18 intestinal FXR/FGF19 signaling, thus elevating hepatic synthesis and fecal excretion.
19
It is well-known that there is an intestinal crosstalk between gut bacteria and BAs. 19 We clarified revealed that CA significantly elevated expressions of bai genes and activity of 7-dehydroxylation for 6 C. scindens, but DCA showed no effect on its 7-dehydroxylation, indicating that BA biotransformation 
